VACCINEX, INC. (VCNX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2024, VACCINEX, INC. reported revenue of $601.0K, up 5.4% from the prior year. The company ran a net loss, with a net margin of -3100.5%. It held $2.60M in total assets against $5.08M in total liabilities.
Key ratios (FY2024)
-3117.3%
Operating margin
-3100.5%
Net margin
+5.4%
Revenue growth (YoY)
| Metric (FY) | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $601.0K | $570.0K | $275.0K | $900.0K | $625.0K | $523.0K | $724.0K | $90.0K | — |
| Cost of Revenue | — | — | — | — | $2.0K | $199.0K | $1.03M | $160.0K | — |
| Operating Income | -$18.73M | -$22.89M | -$19.91M | -$22.49M | -$28.33M | -$32.02M | -$27.28M | -$21.10M | — |
| Net Income | -$18.63M | -$20.25M | -$19.82M | -$22.38M | -$28.85M | -$31.86M | -$29.52M | -$18.72M | — |
| EPS (Diluted) | $-8.88 | $-43.68 | $-98.05 | $-0.78 | — | — | — | — | — |
| Total Assets | $2.60M | $3.63M | $7.98M | $9.84M | $11.70M | $4.60M | $22.03M | $5.58M | — |
| Total Liabilities | $5.08M | $5.94M | $2.78M | $2.43M | $14.31M | $6.88M | $6.69M | $7.35M | — |
| Shareholders' Equity | -$2.49M | -$2.31M | $5.19M | $7.41M | -$2.61M | -$2.27M | $15.34M | -$113.49M | -$107.06M |
| Cash & Equivalents | $1.11M | $1.53M | $6.39M | $8.59M | $10.60M | $2.78M | $5.62M | $4.18M | $1.66M |
| Operating Cash Flow | -$16.19M | -$21.38M | -$19.07M | -$25.30M | -$28.65M | -$30.71M | -$25.28M | -$21.39M | — |
| Capital Expenditures | $22.0K | $67.0K | $99.0K | $32.0K | $290.0K | $78.0K | $235.0K | $68.0K | — |
| Shares Outstanding | 2.68M | 892.6K | 237.5K | 30.80M | 22.39M | 14.89M | 11.48M | 1.10M | — |